Rapport Therapeutics

RAPP · NASDAQ

$29.37+$0.77 (+2.69%)TodayMarket closed ·
Prev close $28.60

Latest news

  • NewsVandana Singh

    Why Is Rapport Therapeutics Stock Trading Higher Today?

  • Press releaseGlobe Newswire

    Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania

  • Press releaseGlobe Newswire

    Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program

  • Press releaseGlobe Newswire

    Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update

  • Press releaseGlobe Newswire

    Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update

  • Press releaseGlobe Newswire

    Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

  • Press releaseGlobe Newswire

    Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting

  • Press releaseGlobe Newswire

    Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

  • Press releaseGlobe Newswire

    Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China

  • Press releaseGlobe Newswire

    Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline

  • NewsAvi Kapoor

    This Extreme Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

  • Press releaseGlobe Newswire

    Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update

  • NewsAvi Kapoor

    Gold Moves Higher; Robinhood Shares Jump

  • NewsAvi Kapoor

    Rapport Therapeutics, Planet Labs, QuantumScape, EchoStar And Other Big Stocks Moving Higher On Monday

  • NewsAvi Kapoor

    Nasdaq Surges 150 Points; Planet Labs Shares Jump After Q2 Results

  • NewsVandana Singh

    Rapport Reports Promising Epilepsy Study Outcomes, Plans Phase 3 Trials Next Year

  • News

    Market-Moving News for September 8th

  • NewsAvi Kapoor

    Phibro Animal Health, Pure Storage, Snowflake, Build-A-Bear Workshop And Other Big Stocks Moving Higher On Thursday

  • Press releaseBusiness Wire

    Alto Neuroscience Appoints Biotech Industry Veteran, Raymond Sanchez, M.D., to Its Board of Directors

  • NewsAvi Kapoor

    ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

  • Press releaseGlobe Newswire

    Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    nCino Posts Weak Earnings, Joins Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

  • Press releaseGlobe Newswire

    Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

  • Press releaseBusiness Wire

    Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.